MHIC
CRDL

Marble Harbor Investment Counsel’s Cardiol Therapeutics CRDL Stock Holding History

Marble Harbor Investment Counsel’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.9K Hold
39,900
– – 0.01% 191
2025
Q4 		$38.1K Hold
39,900
– – ﹤0.01% 184
2025
Q3 		$42.7K Hold
39,900
– – ﹤0.01% 189
2025
Q2 		$54.3K Buy
39,900
+3,000
+8% +$3.49K 0.01% 202
2025
Q1 		$35.8K Hold
36,900
– – ﹤0.01% 205
2024
Q4 		$47.2K Hold
36,900
– – 0.01% 205
2024
Q3 		$73.1K Hold
36,900
– – 0.01% 209
2024
Q2 		$74.5K Hold
36,900
– – 0.01% 203
2024
Q1 		$66.8K Hold
36,900
– – 0.01% 203
2023
Q4 		$31.1K Hold
36,900
– – ﹤0.01% 197
2023
Q3 		$33K Hold
36,900
– – ﹤0.01% 188
2023
Q2 		$32.8K Hold
36,900
– – ﹤0.01% 187
2023
Q1 		$18K Hold
36,900
– – ﹤0.01% 189
2022
Q4 		$18.8K Hold
36,900
– – ﹤0.01% 184
2022
Q3 		$38K Sell
36,900
-1,250
-3% -$1.52K 0.01% 172
2022
Q2 		$50K Buy
38,150
+9,250
+32% +$13.2K 0.01% 180
2022
Q1 		$44K Buy
28,900
+6,000
+26% +$9.9K 0.01% 189
2021
Q4 		$42K Buy
22,900
+900
+4% +$2.49K ﹤0.01% 195
2021
Q3 		$91K Buy
+22,000
New +$79.7K 0.01% 189

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marble Harbor Investment Counsel's CRDL Position: Q1 2026 in Review

Marble Harbor Investment Counsel held its Cardiol Therapeutics (CRDL) position steady in Q1 2026 at 39,900 shares worth $53.9K. The position accounts for 0.01% of the portfolio, ranked #191.

Marble Harbor Investment Counsel first reported a position in CRDL in Q3 2021 and has held it in 19 quarters since. The position peaked at $91K in Q3 2021. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Marble Harbor Investment Counsel held 39,900 shares of Cardiol Therapeutics worth $53.9K as of Q1 2026.
  • Marble Harbor Investment Counsel left its Cardiol Therapeutics share count unchanged in Q1 2026.
  • Cardiol Therapeutics made up 0.01% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #191 holding.
  • Marble Harbor Investment Counsel first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Marble Harbor Investment Counsel's Cardiol Therapeutics position peaked at $91K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.